verapamil has been researched along with Brugada Syndrome in 5 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Brugada Syndrome: An autosomal dominant defect of cardiac conduction that is characterized by an abnormal ST-segment in leads V1-V3 on the ELECTROCARDIOGRAM resembling a right BUNDLE-BRANCH BLOCK; high risk of VENTRICULAR TACHYCARDIA; or VENTRICULAR FIBRILLATION; SYNCOPAL EPISODE; and possible sudden death. This syndrome is linked to mutations of gene encoding the cardiac SODIUM CHANNEL alpha subunit.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Simvastatin (SV) leads to reduction of ventricular rhythm during atrial fibrillation on rabbit atrioventricular (AV) nodes." | 7.81 | Acute effects of simvastatin to terminate fast reentrant tachycardia through increasing wavelength of atrioventricular nodal reentrant tachycardia circuit. ( Alizadeh, AM; Aminolsharieh Najafi, S; Khori, V; Moheimani, HR; Nayebpour, M; Shakiba, D; Zahedi, M, 2015) |
| "Brugada syndrome is a disease characterized by a specific electrocardiographic pattern and an increased risk of sudden cardiac death." | 5.46 | A Report of Brugada Syndrome Presenting with Cardiac Arrest Triggered by Verapamil Intoxication. ( Atar, İ; Erdoğan, İ; Varan, B; Yakut, K, 2017) |
| " The Ito agonist NS5806, sodium channel blocker ajmaline, calcium channel blocker verapamil or hypothermia (32°C) were used to pharmacologically mimic the genetic defects and conditions associated with JWS, thus eliciting prominent J waves and provoking VT/VF." | 3.96 | Acacetin suppresses the electrocardiographic and arrhythmic manifestations of the J wave syndromes. ( Ackerman, MJ; Antzelevitch, C; Barajas-Martinez, H; Borbáth, V; Burashnikov, A; Clatot, J; Di Diego, JM; Hu, D; Li, GR; Patocskai, B; Robinson, VM, 2020) |
| "Simvastatin (SV) leads to reduction of ventricular rhythm during atrial fibrillation on rabbit atrioventricular (AV) nodes." | 3.81 | Acute effects of simvastatin to terminate fast reentrant tachycardia through increasing wavelength of atrioventricular nodal reentrant tachycardia circuit. ( Alizadeh, AM; Aminolsharieh Najafi, S; Khori, V; Moheimani, HR; Nayebpour, M; Shakiba, D; Zahedi, M, 2015) |
| "Brugada syndrome is a disease characterized by a specific electrocardiographic pattern and an increased risk of sudden cardiac death." | 1.46 | A Report of Brugada Syndrome Presenting with Cardiac Arrest Triggered by Verapamil Intoxication. ( Atar, İ; Erdoğan, İ; Varan, B; Yakut, K, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Di Diego, JM | 1 |
| Patocskai, B | 2 |
| Barajas-Martinez, H | 2 |
| Borbáth, V | 1 |
| Ackerman, MJ | 1 |
| Burashnikov, A | 1 |
| Clatot, J | 1 |
| Li, GR | 1 |
| Robinson, VM | 1 |
| Hu, D | 2 |
| Antzelevitch, C | 2 |
| Yakut, K | 1 |
| Erdoğan, İ | 1 |
| Varan, B | 1 |
| Atar, İ | 1 |
| Koncz, I | 1 |
| Gurabi, Z | 1 |
| Panama, BK | 1 |
| Szél, T | 1 |
| Khori, V | 1 |
| Alizadeh, AM | 1 |
| Moheimani, HR | 1 |
| Zahedi, M | 1 |
| Aminolsharieh Najafi, S | 1 |
| Shakiba, D | 1 |
| Nayebpour, M | 1 |
| Morita, H | 1 |
| Zipes, DP | 1 |
| Morita, ST | 1 |
| Wu, J | 1 |
5 other studies available for verapamil and Brugada Syndrome
| Article | Year |
|---|---|
Acacetin suppresses the electrocardiographic and arrhythmic manifestations of the J wave syndromes.
Topics: Ajmaline; Animals; Brugada Syndrome; Disease Models, Animal; Dogs; Drug Evaluation, Preclinical; Ele | 2020 |
A Report of Brugada Syndrome Presenting with Cardiac Arrest Triggered by Verapamil Intoxication.
Topics: Adolescent; Ajmaline; Anti-Arrhythmia Agents; Brugada Syndrome; Diagnosis, Differential; Electrocard | 2017 |
Mechanisms underlying the development of the electrocardiographic and arrhythmic manifestations of early repolarization syndrome.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Brugada Syndrome; Cardiac | 2014 |
Acute effects of simvastatin to terminate fast reentrant tachycardia through increasing wavelength of atrioventricular nodal reentrant tachycardia circuit.
Topics: Animals; Arrhythmias, Cardiac; Atrial Fibrillation; Atrioventricular Node; Brugada Syndrome; Cardiac | 2015 |
Genotype-phenotype correlation in tissue models of Brugada syndrome simulating patients with sodium and calcium channelopathies.
Topics: Action Potentials; Adrenergic beta-Agonists; Animals; Anti-Arrhythmia Agents; Body Surface Potential | 2010 |